{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T01:25:04Z","timestamp":1762478704394,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA138292"],"award-info":[{"award-number":["P30CA138292"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011621","name":"Winship Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020494","name":"Davidson College","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020494","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ethics, Medicine and Public Health"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.jemep.2023.100877","type":"journal-article","created":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T12:39:34Z","timestamp":1677847174000},"page":"100877","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Accounting for the high enrollment of African Americans on Winship Cancer Institute's myeloma clinical trials"],"prefix":"10.1016","volume":"27","author":[{"given":"T.S.","family":"McClary","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.M.","family":"Blee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.M.","family":"Avinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q.","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Switchenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.D.","family":"Dixon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.D.","family":"Pentz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jemep.2023.100877_bib0110","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1182\/blood-2010-07-298760","article-title":"Racial disparities in incidence and outcome in multiple myeloma: a population-based study","volume":"116","author":"Waxman","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jemep.2023.100877_bib0115","first-page":"202","article-title":"Cancer statistics for African American\/Black people 2022","volume":"72","author":"Giaquinto","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jemep.2023.100877_bib0120","unstructured":"International Myeloma Foundation. Disparities in African Americans: https:\/\/www.myeloma.org\/IMF-Diversity-Equity-Inclusion-Policy\/disparities-african-americans, Accessed 2.11.2023."},{"key":"10.1016\/j.jemep.2023.100877_bib0125","unstructured":"United States Food and Drug Administration. Drug Trials Snapshots: NINLARO. https:\/\/www.fda.gov\/drugs\/drug-approvals-and-databases\/drug-trials-snapshots-ninlaro. Accessed 2\/11\/2023."},{"key":"10.1016\/j.jemep.2023.100877_bib0130","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1038\/s41591-018-0303-4","article-title":"Diversifying clinical trials","volume":"24","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.jemep.2023.100877_bib0135","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1182\/bloodadvances.2021005482","article-title":"Analysis of racial and ethnic disparities in multiple myeloma US FDA drug approval trials","volume":"6","author":"Kanapuru","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jemep.2023.100877_bib0140","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/cncr.23157","article-title":"Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review","volume":"112","author":"Ford","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.jemep.2023.100877_bib0145","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cct.2013.03.007","article-title":"A systematic review of the factors influencing African Americans\u2019 participation in cancer clinical trials","volume":"35","author":"Rivers","year":"2013","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.jemep.2023.100877_bib0150","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1002\/cncr.11213","article-title":"Barriers to the participation of African-American patients with cancer in clinical trials: a pilot study","volume":"97","author":"Advani","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.jemep.2023.100877_bib0155","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1089\/jpm.2012.0413","article-title":"Clinical trial participation among ethnic\/racial minority and majority patients with advanced cancer: what factors most influence enrollment?","volume":"16","author":"Jimenez","year":"2013","journal-title":"J Palliat Med"},{"key":"10.1016\/j.jemep.2023.100877_bib0160","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.3332\/ecancer.2021.1307","article-title":"African American participation in cancer clinical trials","volume":"15","author":"Swaby","year":"2021","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.jemep.2023.100877_bib0165","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/1097-0142(20010101)91:1+<233::AID-CNCR10>3.0.CO;2-8","article-title":"Factors that influence African-Americans\u2019 willingness to participate in medical research studies","volume":"91","author":"Shavers","year":"2001","journal-title":"Cancer"},{"year":"2022","author":"Khurana","key":"10.1016\/j.jemep.2023.100877_bib0170"},{"key":"10.1016\/j.jemep.2023.100877_bib0175","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.2105\/AJPH.2011.300279","article-title":"Challenging assumptions about minority participation in US clinical research","volume":"101","author":"Fisher","year":"2011","journal-title":"Am J Public Health"},{"key":"10.1016\/j.jemep.2023.100877_bib0180","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1007\/s40615-017-0452-z","article-title":"Impact of race versus education and race versus income on patients\u2019 motivation to participate in clinical trials","volume":"5","author":"Kurt","year":"2018","journal-title":"J Racial Ethn Health Disparities"},{"issue":"9 Suppl","key":"10.1016\/j.jemep.2023.100877_bib0185","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1002\/1097-0142(19941101)74:9+<2687::AID-CNCR2820741817>3.0.CO;2-B","article-title":"Clinical trial participation. Viewpoints from racial\/ethnic groups","volume":"74","author":"Roberson","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.jemep.2023.100877_bib0190","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G","article-title":"Whatever happened to qualitative description?","volume":"23","author":"Sandelowski","year":"2000","journal-title":"Res Nurs Health"},{"key":"10.1016\/j.jemep.2023.100877_bib0195","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1097\/01.mlr.0000228023.37087.cb","article-title":"Measuring trust in medical researchers","volume":"44","author":"Hall","year":"2006","journal-title":"Med Care"},{"key":"10.1016\/j.jemep.2023.100877_bib0200","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1002\/cncr.24360","article-title":"Measuring therapeutic alliance between oncologists and patients with advanced cancer: the Human Connection Scale","volume":"115","author":"Mack","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.jemep.2023.100877_bib0205","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3390\/rel1010078","article-title":"The Duke University Religion Index (DUREL): a five-item measure for use in epidemological studies","volume":"1","author":"Koenig","year":"2010","journal-title":"Religions"},{"key":"10.1016\/j.jemep.2023.100877_bib0210","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1001\/jama.279.22.1801","article-title":"Influence of socioeconomic and cultural factors on racial differences in late-stage presentation of breast cancer","volume":"279","author":"Lannin","year":"1998","journal-title":"JAMA"}],"container-title":["Ethics, Medicine and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352552523000087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352552523000087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T01:20:32Z","timestamp":1762478432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352552523000087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":21,"alternative-id":["S2352552523000087"],"URL":"https:\/\/doi.org\/10.1016\/j.jemep.2023.100877","relation":{},"ISSN":["2352-5525"],"issn-type":[{"type":"print","value":"2352-5525"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Accounting for the high enrollment of African Americans on Winship Cancer Institute's myeloma clinical trials","name":"articletitle","label":"Article Title"},{"value":"Ethics, Medicine and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jemep.2023.100877","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100877"}}